John D. Quisel - 08 Jul 2024 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IRON
Reported as of: 08 Jul 2024
Net transaction value: +$3,030
SEC form: 4
Accepted by SEC: 10 Jul 2024, 16:15:02 UTC
Prior SEC filing: 06 Jun 2024
Next SEC filing: 18 Dec 2024
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 10 Jul 2024.

Key facts

This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Jul 2024, 16:15.

Change

Previous filing in this sequence was filed on 06 Jun 2024.
Current net transaction value: +$3,030.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IRON transaction

Common Stock

Options Exercise

Transaction value: $3,030
Shares: +3,000
Change %: +4.3%
Price: $1.01^*
Shares after: 72,065
Date: 08 Jul 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -3,000
Change %: -1.2%
Price: $0.000000
Shares after: 238,211
Date: 08 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,000
Exercise price: $1.01
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option are fully vested and exercisable as of the date hereof.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .